Abstract: The present invention relates to a pharmaceutical composition comprising a compound promoting the expression and/or the activity of the non-coding RNA (ncRNA) of SEQ ID NO: 1 or a sequence being at least 85% identical thereto.

Abstract: A method for ascertaining a state of charge of an energy storage unit of a measuring device and/or a probable remaining operating time of the measuring device, includes capturing a plurality of voltage measured values for the voltage dropped across the energy storage unit and a plurality of current measured values for the current provided by the energy storage unit within a respective ascertainment interval. Subsequently, the state of charge associated with the respective ascertainment interval and/or the remaining running time associated with the ascertainment interval are ascertained in each case depending on the plurality of voltage measured values and current measured values. A measuring device for capturing a measured variable is also provided.

Abstract: The present invention relates to a long non-coding RNA as a therapeutic target in cardiac disorders.

Abstract: The invention provides a viral vector particle based on AAV2, which in its capsid protein (CAP) contains an inserted amino acid section which confers tropism for cardiomyocytes.